Meeder Asset Management Inc Durect Corp Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$1.6 - $2.02 $1 - $2	-1 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$1.86 - $2.87 $1 - $2	1 New	1 $0
Q2 2019 Aug 05, 2019	SELL	$0.51 - $0.86 $1,191 - $2,009	-2,337 Closed	0 $0
Q4 2018 Jan 17, 2019	SELL	$0.48 - $1.1 $2,612 - $5,987	-5,443 Reduced 69.96%	2,337 $0
Q3 2018 Nov 02, 2018	BUY	$1.06 - $1.69 $6,704 - $10,689	6,325 Added 434.71%	7,780 $0
Q2 2018 Jul 24, 2018	BUY	$1.56 - $2.51 $870 - $1,400	558 Added 62.21%	1,455 $0
Q1 2018 May 03, 2018	SELL	$0.91 - $2.24 $1,698 - $4,182	-1,867 Reduced 67.55%	897 $2,000
Q4 2017 Feb 02, 2018	BUY	$0.78 - $2.1 $1,162 - $3,129	1,490 Added 116.95%	2,764 $3,000
Q3 2017 Oct 20, 2017	BUY	$1.55 - $1.82 $1,974 - $2,318	1,274	1,274 $2,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $205M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.